Transient cefuroxime/metronidazole treatment induced factor V antibodies

Sjoerd Adrianus Antonius Van den Berg*, Patricia E Verwer, René N Idema, Coen Van Guldener

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

2 Citations (Scopus)

Abstract

A 29-year-old patient presented with an appendicular infiltrate, initially treated with intravenous antibiotics, but later requiring percutaneous drainage. Both prothrombin time (PT) and activated partial thromboplastin time (aPTT) were prolonged on 3 days of antibiotic treatment and unresponsive to vitamin K or prothrombin complex concentrate. Laboratory investigation ultimately showed reduced factor V activity and factor V antibodies. In contrast to previously described cases of factor V antibodies, PT and aPTT were only mildly prolonged and residual factor V activity was still >20%. Draining of the abscess did not induce significant bleeding. Afterwards, no haemostatic medication was required. The patient was discharged from the hospital without complications. One week after cessation of the antibiotic treatment, PT and aPTT were within normal range again, with a factor V activity level of 36%. In conclusion, we present a patient with transient factor V antibodies, induced by antibiotics, without clinical bleeding tendency.

Original languageEnglish
JournalBMJ Case Reports
Volume2014
DOIs
Publication statusPublished - 19 Aug 2014
Externally publishedYes

Bibliographical note

2014 BMJ Publishing Group Ltd.

Fingerprint

Dive into the research topics of 'Transient cefuroxime/metronidazole treatment induced factor V antibodies'. Together they form a unique fingerprint.

Cite this